CD38‐Specific CAR Integrated into <i>CD38</i> Locus Driven by Different Promoters Causes Distinct Antitumor Activities of T and NK CellsChan Liao, Jie Sun, Chun Zhou et al.|Advanced Science|2023Cited by 29
Bispecific killer cell engager-secreting CAR-T cells redirect natural killer specificity to enhance antitumour responsesYa Fan, Jie Sun, Yanting Duan et al.|Nature Biomedical Engineering|2025Cited by 15
<p>Coexistence Of A Huge Venous Thromboembolism And Bleeding Tendency In Cytokine Release Syndrome During CAR-T Therapy</p>Haiyan Liu, Hongming Huang, Jie Jiang et al.|OncoTargets and Therapy|2019Cited by 10
CD97-directed CAR-T cells with enhanced persistence eradicate acute myeloid leukemia in diverse xenograft modelsKai Shang, Jie Sun, Deyu Huang et al.|Cell Reports Medicine|2025Cited by 5